May 2026, Volume 4, Issue 5

Author

Minu Bajpai and Abhijat C. Sheth

Abstract

India stands at a decisive juncture in the evolution of regenerative medicine. Over the past two decades, the country has developed a strong foundation in stem cell science, supported by academic excellence, clinical diversity, and a growing innovation ecosystem. However, the transition from exploratory research to scalable, evidence-based regenerative medicine remains incomplete. The core issue is not the absence of scientific capability, but the absence of systemic coherence across regulation, translation, manufacturing, and delivery.